HIVE saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 29, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 37 instances where the indicator turned negative. In 34 of the 37 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In 71 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
HIVE moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HIVE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
The 50-day moving average for HIVE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
HIVE broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HIVE entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.972) is normal, around the industry mean (3.532). P/E Ratio (9.174) is within average values for comparable stocks, (8.846). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.708) among similar stocks. P/S Ratio (2.169) is also within normal values, averaging (16.763).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. HIVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for SGRX just turned positive on September 21, 2026. Looking at past instances where SGRX's MACD turned positive, the stock continued to rise in 30 of 39 cases over the following month. The odds of a continued upward trend are 77%.
Following a +42.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where SGRX advanced for three days, in 188 of 213 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
SGRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on September 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SGRX as a result. In 80 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for SGRX entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.281) is normal, around the industry mean (2.669). P/E Ratio (-0.024) is within average values for comparable stocks, (16.523). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.112) among similar stocks. P/S Ratio (8.764) is also within normal values, averaging (139.965).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. SGRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
HIVE | SGRX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 51 | 47 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | 49 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 89 | 98 | |
P/E GROWTH RATING 1..100 | 14 | 5 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SGRX's Valuation (49) in the null industry is in the same range as HIVE (66) in the Computer Communications industry. This means that SGRX’s stock grew similarly to HIVE’s over the last 12 months.
SGRX's Profit vs Risk Rating (100) in the null industry is in the same range as HIVE (100) in the Computer Communications industry. This means that SGRX’s stock grew similarly to HIVE’s over the last 12 months.
HIVE's SMR Rating (98) in the Computer Communications industry is in the same range as SGRX (100) in the null industry. This means that HIVE’s stock grew similarly to SGRX’s over the last 12 months.
HIVE's Price Growth Rating (89) in the Computer Communications industry is in the same range as SGRX (98) in the null industry. This means that HIVE’s stock grew similarly to SGRX’s over the last 12 months.
SGRX's P/E Growth Rating (5) in the null industry is in the same range as HIVE (14) in the Computer Communications industry. This means that SGRX’s stock grew similarly to HIVE’s over the last 12 months.
| HIVE | SGRX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 73% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 78% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 88% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 90% | 2 days ago 77% |
| TrendWeek ODDS (%) | 1 day ago 88% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 88% | 1 day ago 90% |
| Advances ODDS (%) | N/A | 7 days ago 88% |
| Declines ODDS (%) | 3 days ago 89% | 1 day ago 90% |
| BollingerBands ODDS (%) | 3 days ago 90% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HIVE’s FA Score shows that 1 FA rating(s) are green while SGRX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HIVE’s TA Score shows that 3 TA indicator(s) are bullish while SGRX’s TA Score has 5 bullish TA indicator(s).
HIVE (@Investment Banks/Brokers) experienced а -9.38% price change this week, while SGRX (@Information Technology Services) price change was -29.54% for the same time period.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -5.09%. For the same industry, the average monthly price growth was -16.78%, and the average quarterly price growth was -13.10%.
The average weekly price growth across all stocks in the @Information Technology Services industry was -1.75%. For the same industry, the average monthly price growth was -5.55%, and the average quarterly price growth was -7.40%.
HIVE is expected to report earnings on Nov 13, 2026.
These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
@Information Technology Services (-1.75% weekly)The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.
A.I.dvisor indicates that over the last year, HIVE has been closely correlated with CLSK. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if HIVE jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To HIVE | 1D Price Change % | ||
|---|---|---|---|---|
| HIVE | 100% | -3.94% | ||
| CLSK - HIVE | 77% Closely correlated | -6.86% | ||
| KEEL - HIVE | 76% Closely correlated | -6.67% | ||
| CIFR - HIVE | 73% Closely correlated | -8.87% | ||
| BTBT - HIVE | 73% Closely correlated | -3.73% | ||
| COIN - HIVE | 73% Closely correlated | -4.51% | ||
More | ||||
A.I.dvisor indicates that over the last year, SGRX has been loosely correlated with COIN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SGRX jumps, then COIN could also see price increases.
| Ticker / NAME | Correlation To SGRX | 1D Price Change % | ||
|---|---|---|---|---|
| SGRX | 100% | -5.00% | ||
| COIN - SGRX | 44% Loosely correlated | -4.51% | ||
| BBAI - SGRX | 29% Poorly correlated | -2.74% | ||
| HIVE - SGRX | 26% Poorly correlated | -3.94% | ||
| MARA - SGRX | 24% Poorly correlated | -6.93% | ||
| RIOT - SGRX | 24% Poorly correlated | -8.06% | ||
More | ||||